Cryo-Cell International, Inc. (CCEL) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-331.7%

-$12.23

vs $5.28 price

Levered DCF

-$1.03

After debt service

Piotroski score

6 / 9

Average

Altman Z-score

-0.05

Distress zone

Rating

C-

Overall 1 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	-13.27×	173.4×	-4.69×	13.24×	47.62×	15.63×	26.03×	-66.55×
P/B	-1.73×	-5.33×	-4.05×	-24.27×	24.08×	-22.91×	-9.13×	-6.13×
P/S	1.02×	2.2×	1.42×	1.22×	3.49×	1.96×	2×	1.87×
EV / EBITDA	39.51×	42.26×	-5.29×	7.05×	17.92×	7.89×	12×	11.22×
Gross margin	76.6%	75.2%	73.1%	71.0%	68.9%	69.0%	68.5%	70.8%
Operating margin	15.3%	10.9%	-39.3%	13.3%	13.9%	24.6%	15.9%	17.8%
Net margin	-7.7%	1.3%	-30.4%	9.1%	7.2%	11.6%	7.2%	-2.9%
Current ratio	0.59×	0.58×	0.45×	0.49×	0.75×	1.13×	1×	1.91×
Debt / equity	-0.62×	-0.98×	-0.99×	-7.62×	0.67×	-2.34×	-1.29×	-1.45×
Interest coverage	2.34×	1.87×	-9.95×	2.64×	2.91×	4.96×	2.97×	3.35×
Dividend yield	10.1%	2.9%	0.0%	20.7%	0.0%	0.0%	0.0%	0.0%
Payout ratio	-133.0%	502.5%	0.0%	276.9%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	13.1%	-3.0%	86.3%	-181.8%	49.8%	-136.0%	-32.9%	9.6%
Return on invested capital	10.8%	1.1%	-20.9%	7.0%	7.7%	16.6%	11.2%	-4.5%
Return on assets	-3.9%	0.6%	-15.6%	4.3%	3.4%	7.8%	5.3%	-2.0%
Free cash flow yield	16.3%	3.4%	2.9%	-23.2%	1.0%	13.1%	8.9%	8.6%
Earnings yield	-7.6%	0.6%	-21.3%	7.5%	2.1%	5.9%	3.6%	-1.6%
Enterprise value	$43.4M	$82.9M	$55.1M	$46.9M	$95.3M	$56.9M	$65.9M	$61.5M
Net debt / EBITDA	10.24×	6.31×	-1.01×	1.49×	-1.02×	-0.57×	0.44×	1.26×
Cash conversion cycle (days)	-43	27	-27	41	43	73	60	705